Biological characterization and complete genome analysis of the newly isolated Serratia liquefaciens phage vB_SlqS

Biological characterization and complete genome analysis of the newly isolated Serratia liquefaciens phage vB_SlqS_ZDD2

Published:2024-01-08 Issue: Volume: Page:
ISSN:
Container-title:
language:
Short-container-title:

Author:

Zhao Qian¹,Han Linzi²,Chu Chen¹,Wang Lili³,Zhuang Likun³,Yuan Rongtao³^ORCID

Affiliation:

1. Qingdao University

2. Qingdao stomatological hospital affiliated to qingdao university

3. Qingdao municipal hospital affiliated to university of health and rehabilitation sciences

Abstract

A novel lytic phage named vB_SlqS_ZDD2 infecting Serratia liquefaciens was isolated from hospital sewage. BLASTn analysis showed that the genome sequence of phage vB_SlqS_ZDD2 shared 0% query coverage with other phages in the NCBI database. Phenotype and phylogeny analysis indicated that this phage might be a new member of the order Caudoviricetes. Genome sequence displayed that phage vB_SlqS_ZDD2 has a 49,178 bp dsDNA with 55% GC content and has 74 open reading frames. Besides, the phage exhibited strong lytic activity and a wide range of pH (3-12) and temperature tolerance (80℃, 80 min).

Publisher

Research Square Platform LLC

Reference12 articles.

1. First pediatric case of infective endocarditis caused by Serratia Liquefaciens;Momose T;Int Heart J,2018

2. Serratia infections: from military experiments to current practice;Mahlen SD;Clin Microbiol Rev,2011

3. Occurrence of yeasts, enterococci and other enteric bacteria in subgingival biofilm of HIV-positive patients with chronic gingivitis and necrotizing periodontitis;Gaetti-Jardim E;Braz J Microbiol,2008

4. Jepsen K, Falk W, Brune F, Cosgarea R, Fimmers R, Bekeredjian-Ding I, Jepsen S (2022) Prevalence and antibiotic susceptibility trends of selected enterobacteriaceae, enterococci, and candida albicans in the Subgingival Microbiota of German Periodontitis Patients: A Retrospective Surveillance Study. Antibiotics (Basel) 11:385. https://doi.org/10.3390/antibiotics11030385

5. Phage Therapy: A different approach to fight bacterial infections;Hibstu Z;Biol-Targets Ther,2022